financetom
Business
financetom
/
Business
/
Manulife, Mahindra to Launch US$800 Million Life Insurance Venture in India
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manulife, Mahindra to Launch US$800 Million Life Insurance Venture in India
Nov 12, 2025 1:16 PM

03:56 PM EST, 11/12/2025 (MT Newswires) -- Manulife Financial ( MFC ) rose 2.73% at last look on Tuesday after the company said it agreed with Mahindra & Mahindra to establish a life insurance joint venture in India, expanding on their existing partnership in the market.

The venture, which remains subject to regulatory approval, aims to serve both rural and urban markets by combining Mahindra's deep distribution reach in semi-urban and rural India with Manulife's agency and insurance expertise. The companies said their goal is to become India's leading life insurer in protection solutions and financial wellbeing.

Each partner will commit up to US$400 million, with initial investments of around US$140 million each over the first five years. The new business builds on the companies' prior collaboration in Mahindra Manulife Investment Management, launched in 2020.

"The agreement marks an important milestone as we seek to enter one of the world's fastest-growing insurance markets," said Manulife CEO Phil Witherington, citing the growth opportunity in India's expanding middle class and supportive regulatory environment.

Mahindra Group CEO Anish Shah said life insurance is a "logical extension" of its financial services portfolio and that the partnership with Manulife "offers a very compelling opportunity to create meaningful value for our shareholders."

India's life insurance market, with more than US$20 billion in new business premiums, has grown at a 12% compound annual rate over the past five years, Manulife said, adding that the country is poised to become the world's fourth-largest life insurance market within a decade.

Manulife shares were last seen up C$1.215 to C$48.215 on the Toronto Stock Exchange.

Price: 48.22, Change: +1.22, Percent Change: +2.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investors react to US attack on Iran nuclear sites
Investors react to US attack on Iran nuclear sites
Jun 21, 2025
(Reuters) -U.S. President Donald Trump on Saturday said that a very successful attack on three nuclear sites in Iran had been carried out. In a posting on Truth Social, Trump added, All planes are safely on their way home and he ended his posting saying, Now is the time for peace. Following are comments from some financial and corporate analysts:...
ARK Invest Dumps $146.3M More Circle Shares After Meteoric 670% IPO Surge
ARK Invest Dumps $146.3M More Circle Shares After Meteoric 670% IPO Surge
Jun 21, 2025
ARK Invest unloaded another round of shares of Circle (CRCL) across its ETFs just two weeks after the stablecoin issuer's high-profile IPO. The biggest cut came from the flagship ARK Innovation ETF ( ARKK ) , which sold 490,549 shares, or about 1.8% of the portfolio. ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds
China's Sciwind's GLP-1 shows similar weight loss to Novo's Wegovy, study finds
Jun 21, 2025
June 21 (Reuters) - Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of 10% to 15% of their body weight, roughly in line with results from a similar drug sold by Novo Nordisk , according to a late-stage study published on Saturday. The drug, called ecnoglutide, belongs to a class of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved